Sternal Closure Systems Global Market Report 2024

The sternal closure systems market has grown strongly in recent years. It will grow from $2.28 billion in 2023 to $2.4 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The historical period witnessed growth attributable to an increase in cardiovascular surgeries, the prevalence of cardiovascular diseases, heightened awareness of sternal complications, collaborations between surgeons and device manufacturers, and a focus on minimally invasive cardiac procedures.

The sternal closure systems market is expected to see strong growth in the next few years. It will grow to $2.95 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The anticipated growth in the forecast period can be credited to the rapid expansion of minimally invasive surgery, a heightened focus on patient-centric healthcare, the increasing prevalence of cardiac surgery in emerging markets, efforts to reduce postoperative complications, and collaborations in research and development. Noteworthy trends expected in the forecast period include technological innovations in device materials, advancements in surgical techniques, the adoption of minimally invasive approaches, developments in sternum fixation technologies, the implementation of wireless remote monitoring, and the emphasis on customization and patient-specific solutions.

The anticipated growth in the sternal closure market is expected to be driven by the rising incidence of chronic diseases. Chronic diseases, characterized by lasting for a year or longer and demanding continuous medical care, often require surgical interventions such as coronary artery bypass grafting (CABG) or valve replacement. Given that these surgeries involve sternal incisions, the importance of effective sternal closure becomes crucial. For instance, a report from the National Institutes of Health (NIH) predicts a 99.5% increase in the number of people aged 50 and older with at least one chronic illness in the United States, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity is projected to rise by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Hence, the growing incidence of chronic diseases is a key driver for the sternal closure market.

A higher prevalence of cardiovascular diseases is expected to propel the sternal closure system market. Many cardiovascular conditions necessitate surgery, during which the sternum bone must be opened. The sternal closure system proves valuable in effectively closing the sternum following such surgeries. For example, research published by the American College of Cardiology indicates a projected 33.8% increase in the risk of stroke to 15 million individuals from 2025 to 2060. Additionally, during the same period, the risk of heart failure is expected to rise by 33.4% to 13 million individuals, heart disease by 30.7% to 29 million individuals, and heart attack by 16.9% to 16 million individuals. Consequently, the heightened prevalence of cardiovascular diseases is a driving force behind the sternal closure system market.

The expected growth in the sternal closure market is anticipated to be fueled by the increasing geriatric population. The geriatric population, comprising individuals aged 65 and older, is more susceptible to sternal complications, such as sternal dehiscence (the separation of the sternum after surgery). The utilization of reinforced sternal closure systems has proven effective and safe in elderly patients undergoing open-heart surgery. According to a report from the World Health Organization (WHO) in October 2022, one in six individuals worldwide will be 60 years or older by 2030. The global population of individuals over 60 is projected to double to 2.1 billion by 2050. Additionally, between 2020 and 2050, there will be an increase of 426 million people aged 80 or older. Consequently, the rising geriatric population is a significant driver for the growth of the sternal closure market.

Major companies are making strategic investments in firms operating in the sternal closure market to enhance customer service. These investments empower companies to develop and introduce innovative sternal closure systems, strengthening their competitive position and propelling market growth. For example, in February 2022, Evonik, a Germany-based specialty chemicals company, invested in CircumFix Solutions, a US-based start-up that developed a new sternal closure device to enhance patient recovery after open-chest surgery. The patented orthopedic device, composed of a high-performance polymer from Evonik, securely closes and holds the sternum together after surgery. This investment aligns with Evonik's strategy to bolster its presence in the U.S. orthopedic market and support the shift from metal to high-performance polymers in implantable medical devices. The innovative sternal closure device is anticipated to improve patient recovery and safety, underscoring Evonik's commitment to advancing medical technology and enhancing patient outcomes.

Product innovations stand out as key trends gaining traction in the sternal closure system market, with major companies introducing innovative products such as the Valkyrie Thoracic Fixation System by Able Medical Devices. Launched in June 2021, this thoracic fixation system is designed for osteotomy and sternum closure following open-heart surgery. Notably, it is the market's first single-use radiolucent plating system, proving highly effective in open-heart surgeries.

Major companies operating in the sternal closure systems market report are Zimmer Biomet Holdings Inc., Johnson and Johnson Services Inc., B. Braun Melsungen AG, Orthofix Holdings Inc., KLS Martin Group GmbH & Co. KG, A&E Medical Corporation, Jace Medical LLC., Acute Innovations LLC., Abyrx Inc., Kinamed Incorporated , Idear SRL, Dispomedica GmbH, Waston Medical Corporation, Jeil Medical Corporation, Figure 8 Surgical, Stryker Corporation, Mercian Labels, Avery Dennison Corporation, Bemis Company Inc., Essentra plc, LINTEC Corporation, SATO Holdings Corporation, Advanced Labels NW, Jet Label & Packaging Ltd., Consolidated Label Co., Axon Enterprise Inc., Progressive Label Inc., Taylor Label Corporation, Praesidia S.R.L., Globus Medical Inc.

North America was the largest region in the sternal closure system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global sternal closure system market report during the forecast period. The regions covered in the sternal closure systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sternal closure systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary product types of sternal closure systems encompass closure devices, bone cement, and are utilized in procedures such as median sternotomy, hemisternotomy, bilateral thoracosternotomy, among others. Sternal closure devices are specifically designed to hold the sternum together during the healing process, reducing the risk of complications and promoting a faster recovery. These devices find application in closing the sternum, or breastbone, following open-heart surgery. Common materials used in sternal closure systems include titanium, polyether ether ketone (PEEK), stainless steel, and others. The system is utilized by various healthcare facilities, including hospitals and clinics, research institutes, and other medical settings.

The sternal closure system market research report provides sternal closure system market statistics, including sternal closure system industry global market size, regional shares, competitors with a sternal closure system market share, detailed sternal closure system market segments, market trends and opportunities, and any further data you may need to thrive in the sternal closure system industry. This sternal closure system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sternal closure system market consists of sales of wires, hooks, and putty that are used for sternal closure procedures. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.